Health Condition 1: C609- Malignant neoplasm of penis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with penile cancers and posted for treatment (Surgery including ILND with /without Radiation Therapy) with curative intent at TMH Mumbai, ACTREC kharghar and HBCH Varanasi. 2.Age > 18. 3.Patients planned for Surgery and or Radiation therapy and or Chemotherapy including Neo adjuvant chemotherapy (NACT) 4.Willing to comply with the Surveillance program. 5.Can read or comprehend either English, Hindi or Marathi.
Exclusion criteria
Exclusion criteria: 1.Patients with unresectable recurrent groin node disease. 2.Patients with swelling/ lymphedema in lower limb at the time of diagnosis of penile cancer. 3.Locally advanced penile cancer patients scheduled for NACT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the incidence of lower limb lymphedema in patients treated for penile cancer with ILND with / without radiation therapy using prospective surveillance program.Timepoint: until 1 year from enrollment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To identify early stage ( 5% 10% volume difference) lower limbs lymphedema in Indian patients treated for penile cancers with IILND with / without radiation therapy using prospective surveillance program.Timepoint: at week 2 and week 6 from the day of surgery | — |
Countries
India
Contacts
Public ContactMohammad Chaudhary
Tata Memorial Hospital,
Outcome results
None listed